Nicorandil-Pretreated Mesenchymal Stem Cell-Derived Exosomes Facilitate Cardiac Repair After Myocardial Infarction via Promoting Macrophage M2 Polarization by Targeting miR-125a-5p/TRAF6/IRF5 Signaling Pathway
Zhao-Ting Gong,Yu-Yan Xiong,Yu Ning,Rui-Jie Tang,Jun-Yan Xu,Wen-Yang Jiang,Xiao-Song Li,Li-Li Zhang,Cheng Chen,Qi Pan,Meng-Jin Hu,Jing Xu,Yue-Jin Yang
DOI: https://doi.org/10.2147/ijn.s441307
IF: 7.033
2024-02-29
International Journal of Nanomedicine
Abstract:Zhao-Ting Gong, 1 Yu-Yan Xiong, 1, 2 Yu Ning, 1 Rui-Jie Tang, 1 Jun-Yan Xu, 3 Wen-Yang Jiang, 1 Xiao-Song Li, 1 Li-Li Zhang, 1 Cheng Chen, 1 Qi Pan, 1 Meng-Jin Hu, 1 Jing Xu, 1 Yue-Jin Yang 1 1 State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100037, People's Republic of China; 2 Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China; 3 Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China Correspondence: Yue-Jin Yang, Email Background: Exosomes derived from bone marrow mesenchymal stem cells (MSC-exo) have been considered as a promising cell-free therapeutic strategy for ischemic heart disease. Cardioprotective drug pretreatment could be an effective approach to improve the efficacy of MSC-exo. Nicorandil has long been used in clinical practice for cardioprotection. This study aimed to investigate whether the effects of exosomes derived from nicorandil pretreated MSC (MSC NIC -exo) could be enhanced in facilitating cardiac repair after acute myocardial infarction (AMI). Methods: MSC NIC -exo and MSC-exo were collected and injected into the border zone of infarcted hearts 30 minutes after coronary ligation in rats. Macrophage polarization was detected 3 days post-infarction, cardiac function as well as histological pathology were measured on the 28th day after AMI. Macrophages were separated from the bone marrow of rats for in vitro model. Exosomal miRNA sequencing was conducted to identify differentially expressed miRNAs between MSC NIC -exo and MSC-exo. MiRNA mimics and inhibitors were transfected to MSCs or macrophages to explore the specific mechanism. Results: Compared to MSC-exo, MSC NIC -exo showed superior therapeutic effects on cardiac functional and structural recovery after AMI and markedly elevated the ratio of CD68 + CD206 + / CD68 + cells in infarcted hearts 3 days post-infarction. The notable ability of MSC NIC -exo to promote macrophage M2 polarization was also confirmed in vitro. Exosomal miRNA sequencing and both in vivo and in vitro experiments identified and verified that miR-125a-5p was an effector of the roles of MSC NIC -exo in vivo and in vitro. Furthermore, we found miR-125a-5p promoted macrophage M2 polarization by inhibiting TRAF6/IRF5 signaling pathway. Conclusion: This study suggested that MSC NIC -exo could markedly facilitate cardiac repair post-infarction by promoting macrophage M2 polarization by upregulating miR-125a-5p targeting TRAF6/IRF5 signaling pathway, which has great potential for clinical translation. Keywords: mesenchymal stem cell, exosomes, nicorandil, macrophage polarization, myocardial infarction Graphical Cardiovascular disease is the leading cause of mortality worldwide, and nearly half of deaths are due to ischemic heart disease. 1,2 Acute myocardial infarction (AMI) is a common disease caused by coronary acute closure, resulting in myocardial damage and functional impairment as consequences. Myocardium necrosis can occur as early as 1h after AMI with inflammatory signaling pathways activated and immune reactions induced. Macrophage is one of the most vigorous cells participating in all stages after AMI, including pro-inflammatory, cardioprotective, and tissue repair phases. 3 In the early stage, macrophages adopt a pro-inflammatory phenotype which can produce pro-inflammatory mediators to recruit lymphocytes and also phagocytize necrotic cells, usually peaking between day 3 and day 5 after AMI. After the infarct area is cleared of cell debris, pro-inflammatory macrophages begin to undergo apoptosis, and newly arrived and differentiated macrophages polarize to anti-inflammatory M2 phenotype which facilitates the resolution of inflammation and tissue repair, peaking on day 7 post-AMI. 4–6 These unique characteristics of macrophages can be a promising target in facilitating cardiac repair for AMI. Mesenchymal stem cell (MSC)-based therapy is regarded as one of the most promising strategies for ischemic heart disease because of easy isolation and expansion, as well as its unique properties of regulating immune response -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology